Evaluate the Incidence of Sacral and Heel Pressure Ulcers During Acute Care After SCI

Sponsor
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal (Other)
Overall Status
Unknown status
CT.gov ID
NCT04165395
Collaborator
Medline Industries (Industry)
165
1
2
16.5
10

Study Details

Study Description

Brief Summary

This study evaluates the effect of the application of a five-layer foam dressing on the sacrum as well as a boot applied on the heels as preventive measures in the development of pressure ulcers in patients hospitalized with spinal cord injury. In order to study their effectiveness in preventing wounds, we will compare the number of wounds that developed on the sacrum and heels in participants with and without preventive treatments. The study will also assess the severity of pressure ulcers in participants with and without preventive treatment if they do develop. Half of the participants will receive the usual standard care for the prevention of pressure ulcers without dressing and boot, while the other half, in additon to standard of care, will also have a preventive dressing on the sacrum as well as Heelmedix boot applied alternately on each foot.

Condition or Disease Intervention/Treatment Phase
  • Device: Five-layer foam dressing
  • Device: Heelmedix boot
N/A

Detailed Description

Among all patient populations, individuals with spinaI cord injury are most vulnerable to pressure ulcers due to prolonged and severe immobilization, moisture exposure related to sphincters incontinence, friction and shear forces associated with difficult transfers, as well as abnormal micro vascular blood flow secondary to a disrupted autonomic function below the level of injury. These factors contribute to ischemia of the skin and underlying tissues over bony prominences, which lead to increased risk of pressure ulcers. Most severe spinal cord injuries are associated with higher risk of developing pressure ulcers and presenting more severe pressure ulcers. The sacral area and heels are most at risk for pressure ulcers in the spinal cord injury population. Consequently, prevention of pressure ulcers during the acute care hospitalization is of utmost importance. Patients will be randomized to the intervention group (prophylactic placement of foam dressing over sacrum and placement of a Heelmedix boot) or the control group (no prophylactic foam dressing over sacrum and no Heelmedix boot). Both groups will receive the standard-of-care at the facility for the prevention of pressure ulcers. The standard care can include a regular evaluation of the skin, a nutritional evaluation, the management of incontinence, the use of a gel mattress, the use of a low air loss pressure-reliving mattress, the use of safe patient mobilization, weekly assessment by a physiatrist, a change of position every 2 hours, as well as occupational therapy and physical therapy.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
165 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Computer generated set of random numbers to determine group allocation with a ratio of 1:1Computer generated set of random numbers to determine group allocation with a ratio of 1:1
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
A Randomized Controlled Trial of the Effectiveness of a Five-layer Foam Dressing and the Heelmedix Boot for the Acute Prevention of Sacral and Heel Pressure Ulcers After Spinal Cord Injury
Actual Study Start Date :
Aug 19, 2019
Anticipated Primary Completion Date :
Jan 1, 2021
Anticipated Study Completion Date :
Jan 1, 2021

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control group

The control group will receive the standard of care adopted at Hôpital du Sacré-Coeur de Montréal in terms of pressure ulcers prevention in the SCI population.

Experimental: Intervention group

In addition to undergoing the identical standard-of-care as the control group, all patients in this group will receive a prophylactic five-layer foam dressing placed directly on the sacral area and a Heelmedix boot installed alternately on both legs

Device: Five-layer foam dressing
Five-layer foam dressing applied on the sacrum within 48 hours of spinal surgery
Other Names:
  • Opitfoam Gentle Silicone Faced Foam & Border Sacral Wound Dressing
  • MSC2377EP
  • Device: Heelmedix boot
    Heelmedix boot will be installed alternately from one foot to the other.
    Other Names:
  • Heelmedix
  • MDT823330P, MDT823330SW, MDT823330XL
  • Outcome Measures

    Primary Outcome Measures

    1. Compare the incidence of pressure ulcers at the sacrum during the acute care hospitalization after a SCI between patients treated with prophylactic five-layer foam dressing at the sacrum area and vs. controls [During the acute care hospitalization, approx 6 weeks]

      Incidence of new PU at the sacrum during the acute care hospitilization

    2. Compare the incidence of PU at the heel during the acute care hospitalization after a SCI between patients with placement of a prophylactic Heelmedix boot and controls [During the acute care hospitalization, approx 6 weeks]

      Incidence of new PU at the heel area during the acute care hospitilization

    Secondary Outcome Measures

    1. Compare the severity of PU at the sacrum during the acute care hospitalization after a SCI between patients treated with prophylactic five-layer foam dressing at the sacrum area and controls [During the acute care hospitalization, approx 6 weeks]

      Grade of PU based on the NPUAP grading system

    2. Compare the severity of PU at the heel during the acute care hospitalization after a SCI between patients with placement of a prophylactic Heelmedix boot and controls [During the acute care hospitalization, approx 6 weeks]

      Grade of PU based on the NPUAP grading system

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Male of female age 18 years of older;

    • Admitted to Hôpital du Sacré-Coeur de Montréal for a traumatic or non-traumatic spinal cord injury;

    • Spinal cord injury is either: Motor-complete (AIS A-B) or motor-incomplete (AIS C);

    • Neurological level of injury is between C0 and L2;

    • Patient or interpreter is able to understand English or French and provide informed consent.

    Exclusion Criteria:
    • AIS D Incomplete spinal cord injury;

    • Cauda equina syndrome or neurological level of injury below L2;

    • Sacral or heel pressure ulcer present at admission;

    • Presence of dermatological disease or systemic disease that might interfere with the outcome assessment (active dermatitis, urticarial, etc.);

    • Skin allergy to any components or ingredients of the foam dressing;

    • Any medical condition that would endanger a patient treated with the foam dressing;

    • Patient who are pregnant or nursing.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 CIUSSS du Nord-de-l'Île-de-Montréal-Hôpital du Sacré-Cœur de Montréal Montréal Quebec Canada H4J 1C5

    Sponsors and Collaborators

    • Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
    • Medline Industries

    Investigators

    • Principal Investigator: Andréane Richard-Denis, M.D., MSC., CIUSSS du Nord-de-l'Île-de-Montréal-Hôpital du Sacré-Cœur de Montréal
    • Study Director: Jean-Marc Mac-Thiong, M.D., Ph. D.,, CIUSSS du Nord-de-l'Île-de-Montréal-Hôpital du Sacré-Cœur de Montréal

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    Responsible Party:
    Andréane Richard-Denis, Principal Investigator, Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
    ClinicalTrials.gov Identifier:
    NCT04165395
    Other Study ID Numbers:
    • 2019-1636
    • ISS-2018-DIV31-014
    First Posted:
    Nov 18, 2019
    Last Update Posted:
    Nov 18, 2019
    Last Verified:
    Sep 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Andréane Richard-Denis, Principal Investigator, Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 18, 2019